Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Karri A. Bauer
Correlation of Checkerboard Synergy Testing With Time-Kill Analysis and Clinical Outcomes of Extensively Drug-Resistant Acinetobacter Baumannii Respiratory Infections
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Related publications
Treatment Options for Carbapenem-Resistant and Extensively Drug-Resistant Acinetobacter Baumannii Infections
Drugs
Pharmacology
Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter Baumannii Clinical Isolates
mBio
Virology
Microbiology
Synergy Effect of Ceftazidime-Avibactam With Meropenem Against Pan-Resistant Acinetobacter Baumannii and Serratia Marcescens Harboring Carbapenemases: Time-Kill and Disk Approximation Assays
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
In-Vitro Efficacy of Polymyxin B With Rifampin, Colistin and Doxycycline Against Extensively Drug Resistant Acinetobacter Baumannii
African Journal of Microbiology Research
Clinical Outcomes of Carbapenem-Resistant Acinetobacter Baumannii Bloodstream Infections: Study of a 2-State Monoclonal Outbreak
Infection Control and Hospital Epidemiology
Epidemiology
Infectious Diseases
Microbiology
Successful Treatment of Extensively Drug-Resistant Acinetobacter Baumannii Ventriculitis With Intravenous Plus Intraventricular Tigecycline- A Case Report
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Treatment of Severe Ventriculitis Caused by Extensively Drug-Resistant Acinetobacter Baumannii by Intraventricular Lavage and Administration of Colistin
Infection and Drug Resistance
Infectious Diseases
Pharmacology
Genomic and Proteomic Characterization of Multi-Drug Resistant Acinetobacter Baumannii
BMC Bioinformatics
Biochemistry
Applied Mathematics
Computer Science Applications
Structural Biology
Molecular Biology
Clinical Outcomes of Colistin in Combination With Either 6-G Sulbactam or Carbapenems for the Treatment of Extensively Drug-Resistant Acinetobacter Baumannii Pneumonia With High MIC to Sulbactam, a Prospective Cohort Study
Infection and Drug Resistance
Infectious Diseases
Pharmacology
